Literature DB >> 2721538

Effect of N-acetylcysteine on plasma cysteine and glutathione following paracetamol administration.

J M Burgunder1, A Varriale, B H Lauterburg.   

Abstract

The effect of oral N-acetyl-L-cysteine (NAC) on plasma sulphhydryls has been studied in healthy volunteers. Following NAC 30 mg.kg-1, total NAC in plasma (i.e. free NAC and NAC as disulphides) reached a median peak concentration of 67 nmol.ml-1 within 45 to 60 min, and disappeared with an apparent half-life of 1.3 h. Only a fraction of total NAC (AUC 163 nmol.ml-1.h) was in the form of free NAC (AUC 12 nmol.ml-1.h, peak concentration 9 nmol.ml-1). Free cysteine was markedly increased (peak increment 49 nmol.ml-1; AUC 80 nmol.ml-1.h). Total cysteine and free and total glutathione in plasma were unchanged. Following the administration of 2 g paracetamol plasma cysteine and glutathione decreased (median decrement in AUC over 3 h was 5.1 nmol.ml-1.h and 3.8 nmol.ml-1.h, respectively). In contrast, the administration of 2 g NAC together with paracetamol resulted in an increase in the AUC of cysteine (+29.2 nmol.ml-1.h) and glutathione (+4.6 nmol.ml-1.h). The data show that NAC leads to a marked increase in circulating cysteine, in part by reacting with cystine and thereby forming mixed disulphides with cysteine and releasing free cysteine as shown in vitro. NAC had no effect on plasma glutathione in the absence of increased stress on the glutathione pools. However, NAC supports glutathione synthesis when the demand for glutathione is increased, as during the metabolism of paracetamol.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2721538     DOI: 10.1007/BF00609183

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  14 in total

1.  Pharmacokinetics and bioavailability of reduced and oxidized N-acetylcysteine.

Authors:  B Olsson; M Johansson; J Gabrielsson; P Bolme
Journal:  Eur J Clin Pharmacol       Date:  1988       Impact factor: 2.953

2.  Determination of non-protein-bound N-acetylcysteine in plasma by high-performance liquid chromatography.

Authors:  B Kågedal; M Källberg; J Mårtensson
Journal:  J Chromatogr       Date:  1984-11-09

3.  N-acetylcysteine: its bioavailability and interaction with ifosfamide metabolites.

Authors:  L R Morgan; M R Holdiness; L E Gillen
Journal:  Semin Oncol       Date:  1983-03       Impact factor: 4.929

4.  Controlled trial of oral N-acetylcysteine in cystic fibrosis.

Authors:  E A Mitchell; R B Elliott
Journal:  Aust Paediatr J       Date:  1982-03

5.  Analysis of biological thiols: derivatization with monobromobimane and separation by reverse-phase high-performance liquid chromatography.

Authors:  G L Newton; R Dorian; R C Fahey
Journal:  Anal Biochem       Date:  1981-07-01       Impact factor: 3.365

6.  Pharmacokinetics of N-acetylcysteine in man.

Authors:  L Borgström; B Kågedal; O Paulsen
Journal:  Eur J Clin Pharmacol       Date:  1986       Impact factor: 2.953

7.  Therapeutic doses of acetaminophen stimulate the turnover of cysteine and glutathione in man.

Authors:  B H Lauterburg; J R Mitchell
Journal:  J Hepatol       Date:  1987-04       Impact factor: 25.083

8.  Mechanism of action of N-acetylcysteine in the protection against the hepatotoxicity of acetaminophen in rats in vivo.

Authors:  B H Lauterburg; G B Corcoran; J R Mitchell
Journal:  J Clin Invest       Date:  1983-04       Impact factor: 14.808

9.  Treatment of paracetamol (acetaminophen) poisoning with N-acetylcysteine.

Authors:  L F Prescott; J Park; A Ballantyne; P Adriaenssens; A T Proudfoot
Journal:  Lancet       Date:  1977-08-27       Impact factor: 79.321

10.  Mechanism of inhibition of glutathione efflux by methionine from isolated rat hepatocytes.

Authors:  T Y Aw; M Ookhtens; N Kaplowitz
Journal:  Am J Physiol       Date:  1986-09
View more
  50 in total

Review 1.  [Good sense and nonsense of antitussive agents].

Authors:  A Gillissen; S Tasci; S Ewig; H Schäfer; S Zielen
Journal:  Internist (Berl)       Date:  2001-01       Impact factor: 0.743

2.  Intracellular thiols regulate activation of nuclear factor kappa B and transcription of human immunodeficiency virus.

Authors:  F J Staal; M Roederer; L A Herzenberg; L A Herzenberg
Journal:  Proc Natl Acad Sci U S A       Date:  1990-12       Impact factor: 11.205

3.  Commentary to "Randomized controlled trial of oral glutathione supplementation on body stores of glutathione".

Authors:  Frederick T Guilford
Journal:  Eur J Nutr       Date:  2015-08       Impact factor: 5.614

4.  Inhibition of development of peripheral neuropathy in streptozotocin-induced diabetic rats with N-acetylcysteine.

Authors:  M Sagara; J Satoh; R Wada; S Yagihashi; K Takahashi; M Fukuzawa; G Muto; Y Muto; T Toyota
Journal:  Diabetologia       Date:  1996-03       Impact factor: 10.122

5.  N-acetylcysteine inhibits the up-regulation of mitochondrial biogenesis genes in livers from rats fed ethanol chronically.

Authors:  Andres A Caro; Matthew Bell; Shannon Ejiofor; Grant Zurcher; Dennis R Petersen; Martin J J Ronis
Journal:  Alcohol Clin Exp Res       Date:  2014-12       Impact factor: 3.455

6.  Cisplatin combined with zidovudine enhances cytotoxicity and oxidative stress in human head and neck cancer cells via a thiol-dependent mechanism.

Authors:  David M Mattson; Iman M Ahmad; Disha Dayal; Arlene D Parsons; Nukhet Aykin-Burns; Ling Li; Kevin P Orcutt; Douglas R Spitz; Kenneth J Dornfeld; Andrean L Simons
Journal:  Free Radic Biol Med       Date:  2008-10-18       Impact factor: 7.376

Review 7.  Environmental toxicity, redox signaling and lung inflammation: the role of glutathione.

Authors:  Saibal K Biswas; Irfan Rahman
Journal:  Mol Aspects Med       Date:  2008-08-08

8.  Radioprotective effect of N-acetylcysteine on granulocyte/macrophage colony-forming cells of human bone marrow.

Authors:  C Selig; W Nothdurft; T M Fliedner
Journal:  J Cancer Res Clin Oncol       Date:  1993       Impact factor: 4.553

9.  Mechanisms of endotoxin-induced haem oxygenase mRNA accumulation in mouse liver: synergism by glutathione depletion and protection by N-acetylcysteine.

Authors:  M Rizzardini; M Carelli; M R Cabello Porras; L Cantoni
Journal:  Biochem J       Date:  1994-12-01       Impact factor: 3.857

10.  Role of renal gamma-glutamyltransferase activity in hepatic utilization of exogenous glutathione.

Authors:  T Tamano; H Yoshida; Y Kuronuma; T Harada
Journal:  J Gastroenterol       Date:  1995-02       Impact factor: 7.527

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.